Patent · US Active

Pharmaceutical oral telmisartan solution

US8871795B2 · kind B2 · utility

6Cited by

2References

16Claims

0Family size

Assignee

Boehringer Ingleheim Vetmedica, Inc. · US

Inventors

Detlef Mohr · Bad Herrenalb, DE
Stefan Lehner · Wiesbaden, DE

Key dates

Filing date	May 19, 2010
Grant date	Oct 28, 2014
Priority date	—
Expiry date	May 19, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P13/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A pharmaceutical solution, preferably a drinkable pharmaceutical solution of the active substance telmisartan is described, having a pH above 10 and additionally containing one or more sugar alcohols added to improve the flavour and shelf life, wherein the sugar alcohols or the pharmaceutical solution have a maximum content of 1000 ppm of reducing sugars.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.